Try our beta test site
13 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND Pixantrone [TREATMENT]
Show Display Options
Rank Status Study
1 Recruiting GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: Obinutuzumab and Pixantrone
2 Completed BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: pixantrone, cyclophosphamide, vincristine, rituximab, prednisone;   Drug: Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
3 Terminated Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: fludarabine and rituximab;   Drug: fludarabine, rituximab, pixantrone
4 Active, not recruiting IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Bendamustine + Rituximab + Pixantrone
5 Unknown  Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Biological: rituximab;   Drug: fludarabine phosphate;   Drug: pixantrone dimaleate
6 Completed A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
Condition: Diffuse Large-Cell Lymphoma
Interventions: Drug: CPOP-R;   Drug: CHOP-R
7 Terminated Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Follicular;   Lymphoma, Mixed-Cell, Follicular;   Lymphoma, Small Cleaved-Cell, Follicular;   Lymphoma, Low-Grade
Interventions: Drug: rituximab;   Drug: Pixantrone (BBR 2778)
8 Unknown  Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cisplatin;   Drug: cytarabine;   Drug: methylprednisolone;   Drug: pixantrone dimaleate;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
9 Recruiting Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN Study
Condition: Malignant Lymphoma
Intervention: Drug: PREBEN
10 Recruiting Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
Conditions: Diffuse Large B-cell Lymphoma;   de Novo DLBCL;   DLBCL Transformed From Indolent Lymphoma;   Follicular Grade 3 Lymphoma
Interventions: Drug: Pixantrone + Rituximab;   Drug: Gemcitabine + Rituximab
11 Unknown  Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cisplatin;   Drug: cytarabine;   Drug: methylprednisolone;   Drug: pixantrone dimaleate
12 Recruiting Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
Conditions: Lymphoma;   Solid Tumor (Excluding CNS)
Intervention: Drug: Pixantrone
13 Completed Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Low-Grade;   Lymphoma, Small Lymphocytic;   Lymphoma, Mixed-Cell, Follicular;   Lymphoma, Small Cleaved-Cell, Follicular
Interventions: Drug: Pixantrone (BBR 2778);   Drug: fludarabine;   Drug: dexamethasone;   Drug: rituximab

Study has passed its completion date and status has not been verified in more than two years.